Fundamentals precomputed nightly
Screener
Screen financial health, valuation and growth. Filing-based scores and market data are refreshed separately, so each figure has a clear source and age.
How this screen works
How do I find financially healthy companies?
Start with a preset — Financial health ranks companies on profitability, debt, cash and accounting quality out of 10. Then narrow it with a maximum P/E, minimum F-Score or sector. Fundamental scores come from filings; price-based fields such as P/E and market value come from the separate market-data refresh.
What does the health score actually measure?
Four fundamental dimensions are averaged: profitability, growth, debt coverage and accounting quality. The score is based on the latest annual filing and does not incorporate the current share price or market valuation.
Quick screens
Financial health
Strong finances across profitability, debt and accounting quality, and improving on most standard checks.
Growth
Sales up sharply on last year, without obvious financial strain.
Value
Making real money, but priced modestly against those profits.
Dividend
Returns cash to shareholders and stays financially sound.
Quality
High margins and returns, carried on a moderate balance sheet.
Red flags
Companies showing financial distress or unusual accounting. Shown so they are not a surprise, not as targets.
Sign in to save a screen and run it again later.
42 companies
Sign in to export| Company | Health | Price | Market value | P/E | Growth | Margin | F-Score | Flags |
|---|---|---|---|---|---|---|---|---|
| INCYINCYTE CORP | 10.0/10 | $116.93+3.08% | $23.21B | 18.04x | 21.2% | 25.0% | 6/8 | |
| BSXBOSTON SCIENTIFIC CORP | 10.0/10 | $46.01+3.37% | $67.90B | 23.48x | 19.9% | 14.4% | 8/9 | |
| ISRGINTUITIVE SURGICAL INC | 10.0/10 | $443.85+3.67% | $157.61B | 55.19x | 20.5% | 28.4% | 7/8 | |
| NBIXNEUROCRINE BIOSCIENCES INC | 10.0/10 | $143.29+1.40% | $14.34B | 29.97x | 21.4% | 16.7% | 5/8 | |
| ZTSZoetis Inc. | 9.0/10 | $82.00+2.99% | $34.84B | 13.04x | 2.3% | 28.2% | 7/9 | |
| ABTABBOTT LABORATORIES | 9.0/10 | $102.51+1.99% | $177.79B | 27.25x | 5.7% | 14.7% | 6/9 | |
| EWEdwards Lifesciences Corp | 9.0/10 | $90.09+1.91% | $52.32B | 48.73x | 11.5% | 17.7% | 6/9 | |
| GILDGILEAD SCIENCES, INC. | 9.0/10 | $157.19+2.36% | $195.07B | 22.92x | 2.4% | 28.9% | 8/9 | |
| SYKSTRYKER CORP | 9.0/10 | $307.08+3.19% | $117.18B | 36.10x | 11.2% | 12.9% | 6/9 | |
| JNJJOHNSON & JOHNSON | 9.0/10 | $267.61+3.81% | $644.30B | 24.04x | 6.0% | 28.5% | 4/9 | |
| LLYELI LILLY & Co | 9.0/10 | $1306.69+2.83% | $1.24T | 60.03x | 44.7% | 31.7% | 7/9 | |
| RMDRESMED INC | 9.0/10 | $253.06+2.79% | $36.50B | 23.96x | 9.9% | 26.9% | 8/9 | |
| MRKMerck & Co., Inc. | 9.0/10 | $147.24-1.76% | $371.93B | 20.38x | 1.3% | 28.1% | 5/9 | |
| IDXXIDEXX LABORATORIES INC /DE | 9.0/10 | $566.76+2.40% | $45.18B | 42.64x | 10.4% | 24.6% | 8/9 | |
| BIIBBIOGEN INC. | 9.0/10 | $253.84+5.34% | $37.26B | 28.82x | 2.2% | 13.1% | 6/9 | |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 8.7/10 | $535.17+2.03% | $135.93B | 34.38x | 8.9% | 32.9% | 6/8 | |
| DXCMDEXCOM INC | 8.7/10 | $78.32-2.42% | $30.14B | 36.04x | 15.6% | 17.9% | 7/8 | |
| PODDINSULET CORP | 8.7/10 | $148.12+4.38% | $10.43B | 42.19x | 30.7% | 9.1% | 7/9 | |
| REGNREGENERON PHARMACEUTICALS, INC. | 8.7/10 | $819.09+1.67% | $85.68B | 19.02x | 1.0% | 31.4% | 6/8 | |
| THCTENET HEALTHCARE CORP | 8.7/10 | $270.63+0.56% | $25.74B | 10.88x | 3.1% | 11.1% | 6/8 | |
| ALGNALIGN TECHNOLOGY INC | 8.7/10 | $155.51+2.73% | $11.10B | 27.04x | 0.9% | 10.2% | 6/8 | |
| BMYBRISTOL MYERS SQUIBB CO | 8.0/10 | $63.00+3.08% | $127.85B | 18.12x | -0.2% | 14.6% | 9/9 | |
| DGXQUEST DIAGNOSTICS INC | 8.0/10 | $243.28+1.82% | $27.00B | 27.22x | 11.8% | 9.0% | 8/9 | |
| MDTMedtronic plc | 8.0/10 | $96.59+3.83% | $123.65B | 25.76x | 8.4% | 13.2% | 7/9 | |
| AMGNAMGEN INC | 8.0/10 | $447.28+2.04% | $240.99B | 31.25x | 10.0% | 21.0% | 8/9 | |
| TECHBIO-TECHNE Corp | 8.0/10 | $72.62-0.03% | $11.34B | 62.33x | -0.4% | 15.0% | 8/9 | |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 7.3/10 | $227.28+0.97% | $30.09B | 95.89x | 65.2% | 8.4% | 5/8 | |
| UHSUNIVERSAL HEALTH SERVICES INC | 7.3/10 | $188.13+2.88% | $11.96B | 8.03x | 9.7% | 8.6% | 7/8 | |
| ABBVAbbVie Inc. | 7.0/10 | $285.19+0.14% | $503.46B | 119.13x | 8.6% | 6.9% | 8/9 | |
| ZBHZIMMER BIOMET HOLDINGS, INC. | 7.0/10 | $98.81+4.16% | $19.67B | 27.90x | 7.2% | 8.6% | 5/9 | |
| BDXBECTON DICKINSON & CO | 7.0/10 | $200.42+3.13% | $57.20B | 34.09x | 8.2% | 7.7% | 6/9 | |
| LHLABCORP HOLDINGS INC. | 7.0/10 | $329.93+1.91% | $27.12B | 30.94x | 7.2% | 6.3% | 8/9 | |
| PFEPFIZER INC | 7.0/10 | $30.42+1.91% | $172.40B | 22.19x | -1.6% | 12.4% | 6/9 | |
| MRNAModerna, Inc. | 6.0/10 | $202.63-17.57% | $79.84B | — | -39.9% | -145.2% | 3/9 | |
| IQVIQVIA HOLDINGS INC. | 6.0/10 | $278.32+0.61% | $47.20B | 34.71x | 5.9% | 8.3% | 5/9 | |
| BAXBAXTER INTERNATIONAL INC | 5.0/10 | $25.65+3.85% | $13.12B | — | 5.7% | -8.5% | 6/9 | |
| OGNOrganon & Co. | 5.0/10 | $13.750.00% | $3.58B | 19.14x | -2.9% | 3.0% | 6/9 | Distress risk |
| DVADAVITA INC. | 4.7/10 | $186.10+5.25% | $12.76B | 17.08x | 6.5% | 5.5% | 6/8 | Distress risk |
| HCAHCA Healthcare, Inc. | 4.7/10 | $467.31+1.72% | $104.96B | 15.47x | 7.1% | 9.0% | 6/8 | Distress risk |
| VTRSViatris Inc | 4.0/10 | $18.48+0.16% | $21.91B | — | -3.0% | -24.7% | 5/9 | Distress risk |
| JAZZJazz Pharmaceuticals plc | 3.3/10 | $214.65+1.26% | $13.19B | — | 4.9% | -8.3% | 5/8 | Distress risk |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.0/10 | $339.66-1.51% | $16.72B | — | -0.9% | -3.6% | 4/8 |